Fuse Medical (FZMD) Stock Price

Fuse Medical Price

OTC·CLOSED
0.02USD+0.00 (+0.00 %)
Market closed

Over the last 12 years Fuse Medical grew revenue by 19.5% annually, reaching 9.02 M USD. Earnings per share have declined at 35.3% per year over the last 7 years. For Fuse Medical, the net margin of 1.5% is up versus -7.8% a few years ago. At today's price the dividend yield works out to roughly 2,500.00%. The stock trades about 1,567% above its 52-week low.

Fuse Medical stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Fuse Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Fuse Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Fuse Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Fuse Medical Stock Price History
DateFuse Medical Price
7/30/20260.02 USD
7/29/20260.02 USD
7/28/20260.02 USD
7/27/20260.02 USD
7/23/20260.02 USD
7/22/20260.02 USD
7/21/20260.02 USD
7/20/20260.02 USD
7/17/20260.02 USD
7/16/20260.02 USD
7/15/20260.03 USD
7/14/20260.03 USD
7/13/20260.03 USD
7/10/20260.03 USD
7/9/20260.03 USD
7/8/20260.02 USD
7/7/20260.02 USD
7/6/20260.02 USD
7/2/20260.02 USD
7/1/20260.02 USD
6/30/20260.02 USD
6/29/20260.02 USD
6/26/20260.02 USD
6/25/20260.02 USD
6/24/20260.02 USD
6/23/20260.02 USD
6/22/20260.02 USD
6/18/20260.02 USD
6/17/20260.02 USD
6/16/20260.02 USD
6/15/20260.02 USD
6/12/20260.02 USD
6/11/20260.02 USD
6/10/20260.02 USD
6/9/20260.03 USD
6/8/20260.03 USD
6/5/20260.03 USD
6/4/20260.03 USD
6/3/20260.03 USD
6/2/20260.03 USD
6/1/20260.03 USD
5/29/20260.03 USD
5/28/20260.03 USD
5/27/20260.03 USD
5/26/20260.03 USD
5/22/20260.03 USD
5/21/20260.03 USD
5/20/20260.03 USD
5/19/20260.03 USD
5/18/20260.03 USD
5/15/20260.03 USD
5/14/20260.03 USD
5/13/20260.03 USD
5/12/20260.02 USD
5/11/20260.03 USD
5/8/20260.03 USD
5/7/20260.03 USD
5/6/20260.03 USD
5/5/20260.03 USD
5/4/20260.03 USD
5/1/20260.03 USD
4/30/20260.03 USD
4/29/20260.03 USD
4/28/20260.03 USD
4/27/20260.03 USD
4/24/20260.03 USD
4/23/20260.03 USD
4/22/20260.03 USD
4/21/20260.03 USD
4/20/20260.02 USD
4/17/20260.02 USD
4/16/20260.02 USD
4/15/20260.02 USD
4/14/20260.02 USD
4/13/20260.02 USD
4/10/20260.02 USD
4/9/20260.02 USD
4/8/20260.02 USD
4/7/20260.02 USD
4/6/20260.02 USD
4/2/20260.02 USD
4/1/20260.02 USD
3/31/20260.02 USD
3/30/20260.02 USD
3/27/20260.02 USD
3/26/20260.01 USD
3/25/20260.02 USD
3/24/20260.02 USD
3/23/20260.02 USD
3/20/20260.02 USD
3/19/20260.02 USD
3/18/20260.02 USD
3/17/20260.02 USD
3/16/20260.02 USD
3/13/20260.02 USD
3/12/20260.02 USD
3/11/20260.02 USD
3/10/20260.02 USD
3/9/20260.02 USD
3/6/20260.02 USD
3/5/20260.02 USD
3/4/20260.02 USD
3/3/20260.02 USD
3/2/20260.02 USD
2/27/20260.02 USD
2/26/20260.02 USD
2/25/20260.02 USD
2/24/20260.02 USD
2/23/20260.02 USD
2/20/20260.02 USD
2/19/20260.02 USD
2/18/20260.02 USD
2/17/20260.02 USD
2/13/20260.02 USD
2/12/20260.02 USD
2/11/20260.02 USD
2/10/20260.02 USD
2/9/20260.02 USD
2/6/20260.02 USD
2/5/20260.02 USD
2/4/20260.02 USD
2/3/20260.02 USD
2/2/20260.02 USD
1/30/20260.02 USD
1/29/20260.01 USD
1/28/20260.01 USD
1/27/20260.01 USD
1/26/20260.01 USD
1/23/20260.01 USD
1/22/20260.01 USD
1/21/20260.01 USD
1/20/20260.01 USD
1/16/20260.01 USD
1/15/20260.01 USD
1/14/20260.01 USD
1/13/20260.01 USD
1/12/20260.01 USD
1/9/20260.01 USD
1/8/20260.01 USD
1/7/20260.01 USD
1/6/20260.01 USD
1/5/20260.01 USD
1/2/20260.01 USD
12/31/20250.01 USD
12/30/20250.01 USD
12/29/20250.01 USD
12/26/20250.01 USD
12/24/20250.01 USD
12/23/20250.01 USD
12/22/20250.01 USD
12/19/20250.01 USD
12/18/20250.01 USD
12/17/20250.01 USD
12/16/20250.01 USD
12/15/20250.01 USD
12/12/20250.01 USD
12/11/20250.01 USD
12/10/20250.01 USD
12/9/20250.01 USD
12/8/20250.01 USD
12/5/20250.01 USD
12/4/20250.01 USD
12/3/20250.01 USD
12/2/20250.01 USD
12/1/20250.01 USD
11/28/20250.01 USD
11/26/20250.01 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
8/8/20250.00 USD
8/7/20250.00 USD
8/6/20250.00 USD
8/5/20250.00 USD
8/4/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Fuse Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
26.34 M USD
3.70 M USD
3.96 M USD
Jan 1, 2019
22.90 M USD
-3.42 M USD
-3.32 M USD
Jan 1, 2020
21.40 M USD
-1.32 M USD
-1.43 M USD
Jan 1, 2021
20.41 M USD
-2.20 M USD
-1.59 M USD
Jan 1, 2022
18.65 M USD
3.29 M USD
3.10 M USD
Jan 1, 2023
16.12 M USD
383,820.00 USD
1.46 M USD
Jan 1, 2024
10.73 M USD
721,412.00 USD
513,960.00 USD
Jan 1, 2025
9.02 M USD
383,783.00 USD
136,912.00 USD

Fuse Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 2, 2026, 2:19 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
–––1.00–1.0025.0026.0026.0022.0021.0020.0018.0016.0010.009.00
––––––2,400.004.00–-15.38-4.55-4.76-10.00-11.11-37.50-10.00
–––600.00–100.0056.0042.3146.1550.0057.1455.0061.1162.5060.0066.67
6.006.006.006.006.001.0014.0011.0012.0011.0012.0011.0011.0010.006.006.00
––––-1.00–3.00–3.00-3.00-1.00-2.003.00–––
––––––12.00–11.54-13.64-4.76-10.0016.67–––
––––-1.00–3.00–3.00-3.00-1.00-1.003.001.00––
–––––––––-200.00-66.67–-400.00-66.67––
0.240.240.240.403.986.266.8965.8954.1270.2275.0070.2273.9070.3270.3270.32
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Fuse Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Fuse Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Fuse Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Fuse Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Fuse Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Fuse Medical stock margins

The Fuse Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fuse Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fuse Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
49.31 %
14.06 %
15.03 %
Jan 1, 2019
48.63 %
-14.93 %
-14.48 %
Jan 1, 2020
59.37 %
-6.16 %
-6.69 %
Jan 1, 2021
58.47 %
-10.76 %
-7.78 %
Jan 1, 2022
61.90 %
17.66 %
16.62 %
Jan 1, 2023
66.61 %
2.38 %
9.06 %
Jan 1, 2024
64.01 %
6.73 %
4.79 %
Jan 1, 2025
71.95 %
4.25 %
1.52 %

Fuse Medical Stock Revenue, EBIT, Earnings per Share

The Fuse Medical earnings per share therefore indicates how much revenue Fuse Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.49 USD
0.07 USD
0.07 USD
Jan 1, 2019
0.33 USD
-0.05 USD
-0.05 USD
Jan 1, 2020
0.29 USD
-0.02 USD
-0.02 USD
Jan 1, 2021
0.29 USD
-0.03 USD
-0.02 USD
Jan 1, 2022
0.25 USD
0.04 USD
0.04 USD
Jan 1, 2023
0.23 USD
0.01 USD
0.02 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Fuse Medical business model & stock analysis

Fuse Medical Inc. is a US-based company specializing in the distribution of orthopedic implants and blood circulation products. Founded in 2014, the company is headquartered in Richardson, Texas. The business model of Fuse Medical is based on the distribution of orthopedic implants, consumables, and instruments to medical practices, hospitals, and surgical facilities. The company works closely with leading manufacturers to offer its customers a wide range of high-quality products. Fuse Medical's product range includes primary and revision implants for various areas such as hips, knees, shoulders, and the spine. In addition, Fuse Medical also offers a wide range of instruments to meet the needs of its customers. These products are supplied by a variety of manufacturers from around the world, allowing Fuse Medical to meet the needs of its customers. In recent years, Fuse Medical has also focused on the distribution of blood circulation products, including non-invasive devices to improve circulation and devices for the treatment of wound healing disorders. These products contribute to improving the quality of life for patients and are an important part of the company's business model. Fuse Medical has experienced good development in recent years and has successfully established itself in the market for orthopedic implants. The company is constantly working to expand its product range and support its customers around the world. This includes continuous training and education of staff to continuously improve the quality of products and customer service. In addition to the distribution of implants and medical devices, Fuse Medical also offers a wide range of services to its customers. This includes fast delivery directly to facilities, inventory management, support for storage, distribution, and maintenance of medical equipment, as well as training for medical personnel. Fuse Medical aims to offer high-quality products and services that meet customer needs and contribute to improving patient care. The company is committed to continuously developing new products through innovation and research that meet the needs of its customers and the latest industry requirements. In summary, Fuse Medical is a successful company specializing in the distribution of orthopedic implants and blood circulation products. The company offers a wide range of products and services and works closely with its customers and manufacturers to ensure the highest quality. Fuse Medical will continue to strive to provide its customers with the best products and services and establish itself as a leading company in the industry. Fuse Medical specializes in the distribution of orthopedic implants and blood circulation products.

Fuse Medical SWOT Analysis

Strengths

Quality medical products

Fuse Medical Inc is known for providing high-quality medical products to the healthcare industry. This reputation has helped them establish strong relationships with their customers and gain a competitive edge in the market.

Innovative technology

The company continuously invests in research and development to bring innovative medical technologies to the market. This allows Fuse Medical Inc to stay at the forefront of the industry and cater to the evolving needs of healthcare professionals.

Diverse product portfolio

Fuse Medical Inc offers a wide range of medical products, including surgical supplies, orthopedic implants, and biologics. This diverse product portfolio allows them to serve a variety of healthcare facilities and target multiple customer segments.

Weaknesses

Limited market presence

Despite their strengths, Fuse Medical Inc has a limited market presence compared to some of their larger competitors. This can hinder their ability to reach a broader customer base and expand their market share.

Dependency on suppliers

The company relies on a network of suppliers to source their medical products. Any disruptions in the supply chain can potentially impact their ability to deliver products on time and meet customer demands.

Higher pricing

Fuse Medical Inc's commitment to quality and innovation often results in higher pricing for their products compared to some competitors. This may make it challenging to attract price-sensitive customers or penetrate price-driven markets.

Opportunities

Growing healthcare industry

The healthcare industry is rapidly expanding due to factors such as aging populations and advancements in medical technology. Fuse Medical Inc can capitalize on this growth by offering their innovative products and expanding their market reach.

Partnerships and collaborations

Forming strategic partnerships and collaborations with other healthcare organizations can provide new opportunities for Fuse Medical Inc. These partnerships can help them access new markets, share resources, and leverage each other's expertise.

Increased demand for personalized healthcare

There is a growing trend towards personalized medicine and healthcare tailored to individual patients. Fuse Medical Inc can explore this opportunity by developing and offering customized medical solutions that meet the unique needs of patients and healthcare providers.

Threats

Intense competition

The medical supplies market is highly competitive, with numerous players vying for market share. Fuse Medical Inc faces competition from both established companies and new entrants, which can pose a threat to their market position.

Changing regulatory landscape

Changes in healthcare regulations and policies can impact the operations of Fuse Medical Inc. Compliance with evolving regulatory standards requires continuous monitoring and adaptation, which can result in additional costs and operational challenges.

Economic uncertainties

Fluctuations in the economy and healthcare spending can have an impact on Fuse Medical Inc's business. Economic downturns or budget cuts in healthcare expenditure can reduce demand for medical supplies and affect the company's financial performance.

Fuse Medical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Fuse Medical Employees
Details
Date
Fuse Medical Employees
Jan 1, 2015
- Employees
Jan 1, 2016
- Employees
Jan 1, 2017
- Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees

Fuse Medical Segments

Fuse Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Fuse Medical historical P/E ratio, EBIT multiple, and P/S ratio

Fuse Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Fuse Medical shares outstanding

The number of shares of Fuse Medical was 70.32 M in 2025. This indicates how many shares Fuse Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
54.12 M Stocks
Jan 1, 2019
70.22 M Stocks
Jan 1, 2020
75.00 M Stocks
Jan 1, 2021
70.22 M Stocks
Jan 1, 2022
73.90 M Stocks
Jan 1, 2023
70.32 M Stocks
Jan 1, 2024
70.32 M Stocks
Jan 1, 2025
70.32 M Stocks

Fuse Medical stock splits

In Fuse Medical's history, there have been no stock splits.

Fuse Medical Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20100.50USD—1×

Fuse Medical dividend payout ratio

In 2025, Fuse Medical had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Fuse Medical distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
0.00 %
Jan 1, 2019
0.00 %
Jan 1, 2020
0.00 %
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
0.00 %
Price targets and forecasts for Fuse Medical are not yet available.

Fuse Medical shareholder structure

% Name
69.38111%
NC 143 Family Holdings, L.P.
NC 143 Family Holdings, L.P.
8.49167%
Reeg Medical Industries, Inc.
Reeg Medical Industries, Inc.
1.89535%
Bosita (Renato V. Jr., M.D.)
Bosita (Renato V. Jr., M.D.)
1.13356%
Reeg (Christopher C.)
Reeg (Christopher C.)
1.13356%
Brooks (Mark W)
Brooks (Mark W)
0.42812%
Yellin (Lawrence Scott)
Yellin (Lawrence Scott)

Fuse Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
14.3%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
30.10%
Twelve Global, LLC
Twelve Global, LLC
SEC ↗
16.20%
CCEP Holdings, LLC
CCEP Holdings, LLC
SEC ↗
13.50%
ReSurge Hospitals, Inc.
ReSurge Hospitals, Inc.
SEC ↗
13.50%
Axis Global, LLC
Axis Global, LLC
SEC ↗
7.02%
BAULCH T
BAULCH T
SEC ↗

Fuse Medical Executives and Management Board

MB

Mr. Mark Brooks

(57)

Chairman of the Board, President, Director · since 2016

Compensation821,000.00 USD
CR

Mr. Christopher Reeg

(59)

Chief Executive Officer, Secretary, Director · since 2016

Compensation354,655.00 USD
LY

Mr. Lawrence Yellin

(65)

Chief Financial Officer, Treasurer, Director · since 2022

Compensation250,000.00 USD
RB

Dr. Renato Bosita

(51)

Independent Director

Frequently asked questions about Fuse Medical

Fuse Medical Inc is a leading medical device distribution company. It operates a unique business model focused on providing comprehensive solutions to healthcare providers. Fuse Medical Inc partners with reputable manufacturers to supply high-quality products across various specialties, including orthopedics, sports medicine, spine, biologics, and pain management. By combining a wide product portfolio with exceptional customer service, Fuse Medical Inc aims to meet the evolving needs of healthcare professionals. With their extensive network and expertise, the company strives to improve patient outcomes while maintaining a strong focus on efficiency and cost-effectiveness.

All fundamentals and in-depth analysis of Fuse Medical

Our stock analysis for Fuse Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuse Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Fuse Medical Stock
Fuse Medical Revenue→
Fuse Medical Stock
Fuse Medical Net Income→
Fuse Medical Stock
Fuse Medical P/E→
Fuse Medical Stock
Fuse Medical P/S→
Fuse Medical Stock
Fuse Medical EBIT→
Fuse Medical Stock
Fuse Medical Dividend→
Fuse Medical Stock
Fuse Medical Directors Dealings→
Fuse Medical Stock
Fuse Medical Stocks→
Fuse Medical Stock
Fuse Medical Market capitalization→
Fuse Medical Stock
Fuse Medical Debt→
Fuse Medical Stock
Fuse Medical Liabilities→
Fuse Medical Stock
Fuse Medical Equity→
Fuse Medical Stock
Fuse Medical AAQS→
Fuse Medical Stock
Fuse Medical Employees→
Fuse Medical Stock
Fuse Medical ROE→
Fuse Medical Stock
Fuse Medical ROA→
Fuse Medical Stock
Fuse Medical ROCE→
Fuse Medical Stock
Fuse Medical News→
Fuse Medical Stock
Fuse Medical Analyst Price Targets→

Health Stocks

Fusen Pharmaceutical CoFunPep CoFuso Pharmaceutical IndustriesFullhope Biomedical CoFuture Care Trading Compnay SJSCFulgent GeneticsFutureChem CoFulcrum TherapeuticsG Medical Innovations HoldingsFukuda Denshi CoG3 Global BhdFujian Cosunter Pharmaceutical CoAll Stocks A–Z →